Myopericardial Diseases : Diagnosis and Management.

Intro -- Preface -- Contents -- Part I: General Evaluation of Myopericardial Diseases -- 1: Essential Anatomy and Physiology of the Pericardium for Clinical Practice -- 1.1 Anatomy of the Pericardium -- 1.2 Physiology of the Pericardium -- References -- 2: Aetiology and Classification of Pericardial Diseases -- 2.1 Overview and Epidemiology -- 2.2 Infectious Aetiologies -- 2.3 Non-infectious Aetiologies -- 2.4 Pericardial Syndromes -- References -- 3: Diagnosis: History, Physical Examination and ECG -- 3.1 History -- 3.2 Physical Examination -- Pericardial Rubs -- Physical Signs in Large Pericardial Effusions/Cardiac Tamponade -- Physical Signs in Constrictive Pericarditis -- 3.3 Electrocardiogram -- References -- 4: Multimodality Imaging of Pericardial/Myopericardial Diseases -- 4.1 Introduction -- 4.2 Chest X-Ray -- 4.3 Echocardiography -- 4.4 Computed Tomography (CT) -- 4.5 Cardiac Magnetic Resonance (CMR) -- 4.6 Nuclear Medicine -- 4.7 Multimodality Imaging -- References -- 5: Cardiac Catheterization and Interventional Techniques -- 5.1 Cardiac Catheterization -- Cardiac Tamponade -- Constrictive Pericarditis -- 5.2 Pericardiocentesis -- 5.3 Pericardioscopy, Pericardial Biopsy and Intrapericardial Therapies -- References -- 6: Principles of Medical Therapy of Pericardial Diseases -- 6.1 Overview -- 6.2 Aspirin and Non-steroidal Anti-inflammatory Drugs (NSAID) -- Mechanism of Action -- Indications -- Main Contraindications, Warnings, Precautions and Interactions -- Adverse Events -- Special Populations -- Common Prescribed Drugs and Dosing -- 6.3 Colchicine -- Mechanism of Action -- Indications -- Main Contraindications, Warnings, Precautions and Interactions -- Adverse Events -- Special Populations -- Common Dosing -- 6.4 Corticosteroids -- Mechanism of Action -- Indications -- Adverse Events -- Special Populations.

Common Dosing -- 6.5 Azathioprine, Human Intravenous Immunoglobulin (IVIG) and Anakinra -- Azathioprine -- Intravenous Immunoglobulins (IVIG) -- Anakinra and Biological Agents -- References -- 7: Surgery for Pericardial Diseases -- 7.1 Introduction -- 7.2 Non-constrictive Pericardial Diseases -- Pericardial Window -- 7.3 Constrictive Pericardial Diseases -- References -- Part II: Myopericardial Syndromes -- 8: Pericardial Syndromes -- References -- 9: Acute Pericarditis: Management Overview -- 9.1 Definition -- 9.2 Presentation -- 9.3 Aetiology and Diagnosis -- 9.4 Diagnostic Work-Up and Management -- 9.5 Therapy -- 9.6 Outcome and Prognosis -- References -- 10: Acute Pericarditis: Specific Aetiologies (Non-viral, Non-idiopathic) -- 10.1 Bacterial Pericarditis -- Tuberculous Pericarditis -- Diagnosis -- Medical Therapy -- Prognosis -- Purulent Pericarditis -- Medical Therapy -- Prognosis -- 10.2 Pericarditis in Renal Failure -- 10.3 Pericardial Involvement in Systemic Autoimmune and Autoinflammatory Diseases -- Medical Therapy -- 10.4 Post-cardiac Injury Syndromes -- Definition and Diagnostic Criteria -- Medical Therapy -- Prognosis -- 10.5 Neoplastic Pericarditis -- Medical Therapy -- 10.6 Radiation Pericarditis -- References -- 11: Recurrent Pericarditis -- 11.1 Definition -- 11.2 Presentation -- 11.3 Aetiology and Diagnosis -- 11.4 Diagnostic Work-Up and Management -- 11.5 Therapy -- 11.6 Outcomes and Prognosis -- References -- 12: Pericarditis Associated with Myocardial Involvement (Myopericarditis/Perimyocarditis) -- 12.1 Definitions -- 12.2 Presentation -- 12.3 Aetiology and Diagnosis -- 12.4 Diagnostic Work-Up and Management -- 12.5 Therapy -- 12.6 Outcomes and Prognosis -- References -- 13: Pericardial Effusion -- 13.1 Definition -- 13.2 Presentation -- 13.3 Aetiology and Diagnosis.

13.4 Diagnostic Work-Up and Management -- 13.5 Therapy -- 13.6 Outcomes and Prognosis -- References -- 14: Cardiac Tamponade -- 14.1 Definition -- 14.2 Presentation -- 14.3 Aetiology and Diagnosis -- 14.4 Diagnostic Work-Up and Management -- 14.5 Therapy -- 14.6 Outcomes and Prognosis -- References -- 15: Constrictive Pericarditis -- 15.1 Definition -- 15.2 Presentation -- 15.3 Aetiology and Diagnosis -- 15.4 Diagnostic Work-Up and Management -- 15.5 Therapy -- 15.6 Outcomes and Prognosis -- References -- 16: Congenital Abnormalities of the Pericardium and Pericardial Masses -- 16.1 Classification -- 16.2 Congenital Abnormalities of the Pericardium -- Pericardial Defects -- Congenital Cysts -- 16.3 Pericardial Masses -- Cysts -- Pericardial Tumours -- Secondary Tumours -- Pericardial Haematomas -- 16.4 Multimodality Imaging for Pericardial Masses and Cysts -- References -- Part III: Specific Populations, Guidelines, Conclusions and Perspectives -- 17: Age and Gender Issues in the Management of Pericardial Diseases -- 17.1 Introduction -- 17.2 Children -- 17.3 Pregnancy and Lactation -- 17.4 The Elderly -- References -- 18: Guidelines on the Management of Pericardial Diseases -- 18.1 Overview and Introduction -- 18.2 What's New in Pericardial Diseases? -- 18.3 How 2015 ESC Guidelines Are Structured and Main Messages -- References -- 19: Conclusions -- 20: Perspectives and Unmet Needs.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.